1. Home
  2. PRME vs UPBD Comparison

PRME vs UPBD Comparison

Compare PRME & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • UPBD
  • Stock Information
  • Founded
  • PRME 2019
  • UPBD 1986
  • Country
  • PRME United States
  • UPBD United States
  • Employees
  • PRME N/A
  • UPBD N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • UPBD Diversified Commercial Services
  • Sector
  • PRME Health Care
  • UPBD Consumer Discretionary
  • Exchange
  • PRME Nasdaq
  • UPBD Nasdaq
  • Market Cap
  • PRME 693.5M
  • UPBD 1.6B
  • IPO Year
  • PRME 2022
  • UPBD 1995
  • Fundamental
  • Price
  • PRME $6.37
  • UPBD $21.51
  • Analyst Decision
  • PRME Buy
  • UPBD Strong Buy
  • Analyst Count
  • PRME 6
  • UPBD 4
  • Target Price
  • PRME $8.88
  • UPBD $37.25
  • AVG Volume (30 Days)
  • PRME 4.3M
  • UPBD 776.9K
  • Earning Date
  • PRME 11-11-2025
  • UPBD 10-30-2025
  • Dividend Yield
  • PRME N/A
  • UPBD 7.20%
  • EPS Growth
  • PRME N/A
  • UPBD 78.87
  • EPS
  • PRME N/A
  • UPBD 1.79
  • Revenue
  • PRME $4,961,000.00
  • UPBD $4,481,986,000.00
  • Revenue This Year
  • PRME $179.58
  • UPBD $10.15
  • Revenue Next Year
  • PRME N/A
  • UPBD $8.62
  • P/E Ratio
  • PRME N/A
  • UPBD $12.10
  • Revenue Growth
  • PRME 739.42
  • UPBD 7.49
  • 52 Week Low
  • PRME $1.11
  • UPBD $19.65
  • 52 Week High
  • PRME $6.94
  • UPBD $36.00
  • Technical
  • Relative Strength Index (RSI)
  • PRME 63.18
  • UPBD 38.82
  • Support Level
  • PRME $5.25
  • UPBD $20.50
  • Resistance Level
  • PRME $6.65
  • UPBD $21.89
  • Average True Range (ATR)
  • PRME 0.61
  • UPBD 0.78
  • MACD
  • PRME -0.03
  • UPBD -0.29
  • Stochastic Oscillator
  • PRME 69.71
  • UPBD 17.63

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

Share on Social Networks: